Putative standards of skeletal alkaline phosphatase (ALP) (from bone, bone cells, osteosarcoma cells, and Pagetic serum) and hepatic ALP (from cholestatic serum and bile) were used to compare three methods for quantifying skeletal ALP activity in serum: heat inactivation, precipitation with wheat germ agglutinin (WGA), and precipitation with concanavalin A (Con A). All the skeletal ALP standards were similarly sensitive to heat inactivation, as were the hepatic ALP standards. Heat inactivation separated skeletal from hepatic ALP by a 50% difference in remaining ALP activities (e.g., 23% and 74% remaining skeletal and hepatic ALP activities after 30 mm at 52 #{176}C). Differential precipitations with WGA and with Con A were less efficient at separating skeletal from hepatic ALP (maximum differences of <30% remaining ALP activity). Although both types of hepatic ALP standard (cholestatic serum and bile) were precipitated with similar efficiencies by WGA and Con A, the skeletal ALP standards were not (e.g., at 2.7 g/L, WGA precipitated 78-86% of the ALP activity in Pagetic serum, but only 49% of the ALP activity in extracts of human bone). These data suggest that heat inactivation is preferable to precipitation with WGA or Con A for quantifying skeletal ALP activity in serum: it better separates skeletal from hepatic ALP activity and is not sensitive to glycosyl heterogeneity. (34)(35)(36)(37)(38).
to the plasma membrane by a phospho-glycan linkage to phosphatidylinosite! and released (to circulation) by a phosphatidylinositol-glycan hydrolase (1) (2) (3) (4) (5) (6) . Although the precise biochemical function of skeletal ALP in bone cells is unknown and the mechanism of release is poorly understood, the enzyme is believed to play a role in bone formation and (or) mineralization (7) (8) (9) , and previous studies indicate that quantitative measurement of skeletal ALP activity in serum can provide an index of the rate of bone formation (10-13). This predictive applicaDepartments of 'Medicine and 2Biochemistry,tion has been limited, however, by a longstanding practical problem: how can we quantify skeletal ALP activity in the presence of other ALP isoenzymes?
Human serum ordinarily contains a variable mixture of ALP isoenzymes from liver, intestine, bone, and (during pregnancy) placenta. These four circulating ALP isoenzymes are the products of three genes. The intestinal and placental ALP isoenzymes are unique gene products, and can be distinguished from skeletal and hepatic ALP activities by characteristic differences in sensitivity to chemical inhibitors, and inactivation by heat (14) (15) (16) (17) (18) (19) (20) .
It is more difficult to distinguish skeletal from hepatic ALP activity, because both isoenzymes are the products of a single gene and differ only with respect to posttrans- We also wanted to compare these two assays with respect to the efficiency (and magnitude) of separating skeletal from hepatic ALP activity.
Finally, because we had recently observed that precipitation with concanavalin A (Con A) was more efficient than precipitation with WGA for quantifying skeletal ALP activity in canine serum (42), we also tested the efficiency of Con A precipitation for quantifying skeletal ALP activity in human serum, and assessed the putative isoenzyme standards as potential calibrators of that assay. for the millimolar absorptivity of p-nitrophenol, an experimentally determined value that applies specifically to our reaction protocol. As reported in previous studies (27, 44), ALP activities determined by this method must be multiplied by a factor of 2.7 for comparison with measurements of ALP activity in 2-amino-2-methyl-1-propanol buffer at 30#{176}C.
Materials and Methods Materials

Partial purification of skeletal and hepatic ALP isoenzyme standards
by Con A-.agarose affinity. ALP activities, from SaOS-2 cells and from bile, were applied to columns of Con A-agarose, in NaHCO3 buffer (25 mmol/L, pH 8.0), containing, per liter, 0.14 mol of NaCl, 1 mmol of MnC12, 1 mmol of MgCl2, 1 mmol of CaC12, and 0.1 g of azide. We rinsed the columns with the same buffer and eluted ALP isoenzymes with a-methylmannoside (50 mL, 0.1 mol/L) to produce two pools of ALP activity: Con A-bound and Con A-unbound.
After concentration and dialysis (in buffer A), these bound and unbound fractions of ALP activity were used to assess heat stability and lectin affinity.
Heat inactivation of ALP activity. As described in previous studies (27,44), heat inactivation was assessed in mixtures of one part serum/HIS, one part buffer A, and Normalhumanbonecell extract.
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Heat inactivation of skeletal and hepatic ALP isoenzyme activated faster than the hepatic standards, both at 55 ± 0.5 #{176}C (as shown in Table 1 ), and at 52 ± 0.5 #{176}C (as summarized in Figure 1 ). Figure 1 also shows to changes in the concentration of serum/HIS differed. As summarized in Table 3 , the maximum differences observed between the isoenzyme standards (i.e., differences in the percentages of remaining ALP activity) were 29.0% for WGA (at a serum proportion of 227 mL/L) and 27.9% for Con A (at a serum proportion of 340 milL). Figure 2 , the Con A-bound and unbound fractions of SaOS-2 cellJskeletal ALP and biliary/hepatic ALP were inactivated at the same rates as the skeletal ALP in Pagetic serum and the hepatic ALP in cholestatic serum, respectively.
As shown in Table 4 , the Con A-bound fraction of skeletal ALP from SaOS-2 cells was more sensitive to precipitation with Con A and WGA than was the Con A-unbound fraction (or the unfractionated cell extract); moreover, the bound fraction more closely resembled the Pagetic serum standard of skeletal ALP. The Con A-bound fraction of hepatic ALP from bile was more 47) and to the rate of ALP activity releasefrom the cells into the culture medium (12, 43) . Together, these observations suggested that quantitative measurement of skeletal ALP activity in serum might provide an index of the bone formation rate; indeed, previous clinical studies have shown that the amount of skeletal ALP activity in serum could be correlated to the rate of bone formation (10, 11, 13) .
This predictive application has been limited, however, because it is technically difficult to quantify skeletal ALP activity in the circulating mixture of ALP activities from liver, intestine, and bone. The technical problem reduces to this: how can we distinguish skeletal from hepatic ALP activity in serum? Previous studies have shown separation of skeletal ALP from hepatic ALP by kinetic, physicochemical, and immunological methods , but none of these methods completely resolves the two isoenzyme activities.
Application of these methods for selective quantification of skeletal ALP activity in serum is, therefore, dependent on internal (within-assay) comparisons with results for calibration standards of skeletal and hepatic ALP activities that mimic the characteristics of the same isoenzymes in serum.
The current studies compared the behavior of several putative standards of skeletal and hepatic ALP isoenzyme activities as potential calibrators of two estab- These differences can be exploited to quantify intestinal ALP activity in serum (19, 20, 26, 27, 44) .
Heat inactivation
showed that all of the putative standards of skeletal ALP were inactivated at similar rates, as were all the putative standards of hepatic ALP. Thus, our data indicate that any of the tested preparations of skeletal and hepatic ALP isoenzyme activities could be used as reference standards for internal calibration of a heat-inactivation assay for quantifying skeletal ALP activity in serum. 
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sensitive to Con A precipitation and less sensitive to WGA precipitation than was the Con A-unbound fraction, and more closely resembled the cholestatic serum standard of hepatic ALP with respect to Con A precipitation.
Treatment of skeletal ALP with neuraminidase. Treatment with neuraminidase had no effect on the sensitivity of Pagetic serum skeletal ALP activity to inactivation by heat (data not shown), but did decrease the efficiency of WGA precipitation (e.g., from 85.5% to 64.6% for WGA at 3 g/L) and increased the efficiency of Con A precipitation (e.g., from 37.2% to 51.1% for Con A at 3.0 gIL, and from 70.6% to 55.1% at 6 g/L). In summary, these studies show that either heat inactivation or lectin precipitation (i.e., with WGA or Con A) can be used to quantify skeletal ALP activity in serum.
Because neither method completely resolves skeletal from hepatic ALP activity, such applications should include internal reference standards of skeletal and hepatic ALP isoenzyme activities for calibrating the assays. In choosing between these alternatives, two observations strongly favor heat inactivation over WGA or Con A precipitation:
heat inactivation was nearly twice as sensitive as WGA (or Con A) precipitation;
and identification and preparation of calibration standards of ALP isoen.zyme activities was much less problematic for heat inactivation than for WGA (or Con A) precipitation.
